Susceptibility to PNU-140690 (Tipranavir) of Human Immunodeficiency Virus Type 1 Isolates Derived from Patients with Multidrug Resistance to Other Protease Inhibitors

In our study we examined the anti-human immunodeficiency virus type 1 (anti-HIV-1) activity of a novel HIV-1 protease inhibitor, PNU-140690 (tipranavir), against patient-derived isolates resistant to multiple other protease inhibitors (PIs). The aim of our experiments was to investigate the genotype...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Rusconi, Stefano, La Seta Catamancio, Simona, Citterio, Paola, Kurtagic, Semir, Violin, Michela, Balotta, Claudia, Moroni, Mauro, Galli, Massimo, d'Arminio-Monforte, Antonella
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2000
Assuntos:	Antiviral Agents
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC89863/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10770770/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.44.5.1328-1332.2000
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!